Following publication of this article, the authors discovered errors in their reporting of the results on IL-6. These mistakes have now been corrected in the published article. The changes made to the original article are detailed below: 2 = 0%). The IgG ratio was increased in schizophrenia (1 study [54 patients]; SMD = 0.68; 95% CI 0.30-1.06), whereas the IgG Albumin ratio was decreased (1 study [32 patients]; SMD = −0.62; 95% CI −1.13 to −0.12). Interleukin-6 (IL-6) levels (7 studies [230 patients]; SMD = 0.55; 95% CI 0.35-0.76; I 2 = 1%) and IL-8 levels (3 studies [95 patients]; SMD = 0.46; 95% CI 0.17-0.75, I 2 = 0%) were increased in schizophrenia but not significantly increased in affective disorders." These authors contributed equally:
compared to healthy controls. Total CSF protein was elevated in both schizophrenia (3 studies [97 patients]; SMD = 0.38; 95% CI 0.12-0.65, I 2 = 0%) and affective disorders (2 studies [53 patients]; SMD = 0.77; 95% CI 0.36-1.18, I 2 = 0%). The IgG ratio was increased in schizophrenia (1 study [54 patients]; SMD = 0.60; 95% CI 0.23-0.98), whereas the IgG Albumin ratio was decreased (1 study [32 patients]; SMD = −0.62; 95% CI −1.13 to −0.12). Interleukin-6 (IL-6) levels (7 studies [230 patients]; SMD = 0.38; 95% CI 0.02-0.74; I 2 = 64%) and IL-8 levels (3 studies [95 patients]; SMD = 0.46; 95% CI 0.17-0.75, I 2 = 0%) were increased in schizophrenia but not significantly increased in affective disorders." was changed to:
"The CSF/serum albumin ratio was increased in schizophrenia (1 study [54 3) In the section 'CSF cell count, total protein, albumin, and albumin ratio' under the heading 'Affective disorders': "In the meta-analysis comparing to healthy controls, cell count was not significantly increased, whereas total protein levels (2 studies "In the meta-analysis comparing to healthy controls, IgG/albumin ratio was decreased (1 study [32 patients]; SMD = −0.62; 95% CI −1.13 to −0.12), IgG ratio was increased (1 study [54 patients]; SMD = 0.60; 95% CI 0.23-0.98), whereas IgG levels and the IgG index were not significantly increased." was changed to: "In the meta-analysis comparing to healthy controls, IgG/ albumin ratio was decreased (1 study [32 patients]; SMD = −0.62; 95% CI −1.13 to −0.12), IgG ratio was increased (1 study [54 patients]; SMD = 0.68; 95% CI 0.30-1.06), whereas IgG levels and the IgG index were not significantly increased." 5) In the section 'CSF interleukins', under the heading 'Schizophrenia spectrum disorders': "In the meta-analysis comparing to healthy controls, IL-8 (3 studies [95 patients]; SMD = 0.46; 95% CI 0.17-0.75; I 2 = 0%) and IL-6 (7 studies [230 patients]; SMD = 0.38; 95% CI 0.02-0.74; I 2 = 64%) were significantly increased. In a post-hoc analysis, we found that IL-6 was only significantly elevated in acute psychosis (SMD = 0.46; 95% CI 0.03-0.90; I 2 = 55%) but not in chronic psychosis (SMD = −0.08; 95% CI −0.77 to 0.60; I 2 = 64%) with the between-group difference being not significant (p = 0.19) (eFigure 3). The levels of IL-1alpha, IL-1beta and IL-2 were not statistically different from healthy controls." was changed to: "In the meta-analysis comparing to healthy controls, IL-8 (3 studies [95 patients]; SMD = 0.46; 95% CI 0.17-0.75; I 2 = 0%) and IL-6 (7 studies [230 patients]; SMD = 0.55; 95% CI 0.35-0.76; I 2 = 1%) were significantly increased. In a post-hoc analysis, we found that IL-6 was significantly elevated in acute psychosis (SMD = 0.46; 95% CI 0.22-0.71; I 2 = 1%) and chronic psychosis (SMD = −0.75; 95% CI 0.39 to 1.12; I 2 = 0%) with the between-group difference being not significant (p = 0.20) (eFigure 3). The levels of IL-1alpha, IL-1beta and IL-2 were not statistically different from healthy controls." 6) A number of changes were also made to Table 2 in the original article. The original, incorrect version of Table 2 is displayed below. Values which have now been corrected in the updated, original article are underlined. Additional rows have also been added to Table 2 in the updated, original article. These rows are 'IL-1 alpha' and 'IL-2'. The authors would like to apologise for these errors. This has been corrected in both the PDF and HTML versions of the Article.
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